Evren Technologies, Inc.
Evren Technologies is a bioelectronic medical device company dedicated to transforming the treatment of PTSD through non-invasive neuromodulation devices that use vagus nerve stimulation (VNS). Their mission is to empower patients to rise above PTSD and improve their lives with portable, innovative products. They develop and commercialize devices like the Phoenix CR system, which administers transcutaneous auricular VNS to alleviate PTSD symptoms, with ongoing clinical trials and FDA interactions.
Industries
Nr. of Employees
small (1-50)
Evren Technologies, Inc.
Products
In-ear wearable transcutaneous auricular stimulation research system (programmable, home-capable)
A discreet in-ear stimulation system designed for laboratory and unsupervised home use with programmable stimulation, biosignal monitoring integration, data logging, remote communication, and adherence tracking.
Phoenix
An earbud device worn daily or while sleeping designed to reduce symptoms of PTSD and promote faster recovery from traumatic events by delivering neurostimulation responding to body stress signals.
Phoenix CR
A transcutaneous auricular vagus nerve stimulation (taVNS) research device designed specifically to produce high-quality data from human clinical trials.
Phoenix 100
The Phoenix 100 is designed to administer transcutaneous auricular VNS (taVNS) safely and effectively using an earpiece that delivers a light electrical tingle to activate the vagus nerve and help reduce PTSD symptoms.
Earpieces
Evren's proprietary, conductive earpieces made of soft silicone and available in 3 sizes - Small, Medium and Large.
In-ear wearable transcutaneous auricular stimulation research system (programmable, home-capable)
A discreet in-ear stimulation system designed for laboratory and unsupervised home use with programmable stimulation, biosignal monitoring integration, data logging, remote communication, and adherence tracking.
Phoenix
An earbud device worn daily or while sleeping designed to reduce symptoms of PTSD and promote faster recovery from traumatic events by delivering neurostimulation responding to body stress signals.
Phoenix CR
A transcutaneous auricular vagus nerve stimulation (taVNS) research device designed specifically to produce high-quality data from human clinical trials.
Phoenix 100
The Phoenix 100 is designed to administer transcutaneous auricular VNS (taVNS) safely and effectively using an earpiece that delivers a light electrical tingle to activate the vagus nerve and help reduce PTSD symptoms.
Earpieces
Evren's proprietary, conductive earpieces made of soft silicone and available in 3 sizes - Small, Medium and Large.
Services
Provision of programmable, research-grade transcutaneous auricular stimulation systems and associated software for clinic and home study deployments.
Support for IRB-approved pilot studies and clinical trial device deployment, including remote monitoring, data collection for clinical endpoints, and collaboration with academic partners.
Execution of government contracts and collaborative projects focused on soldier safety, performance research, and applied neuromodulation studies with academic partners.
Provision of programmable, research-grade transcutaneous auricular stimulation systems and associated software for clinic and home study deployments.
Support for IRB-approved pilot studies and clinical trial device deployment, including remote monitoring, data collection for clinical endpoints, and collaboration with academic partners.
Execution of government contracts and collaborative projects focused on soldier safety, performance research, and applied neuromodulation studies with academic partners.
Expertise Areas
- Neuromodulation device development
- Transcutaneous auricular vagus nerve stimulation research
- Closed-loop adaptive neuromodulation
- In-ear wearable medical device design
Key Technologies
- Transcutaneous auricular vagus nerve stimulation (taVNS)
- In-ear wearable neuromodulation hardware
- Programmable electrical stimulation and waveform control
- Closed-loop adaptive stimulation algorithms
News & Updates
Evren is partnered with Emory University and Dr. Doug Bremner, a leading PTSD researcher, supporting soldier safety and performance.
The company announced the completion of an IRB-approved pilot study using the Phoenix device, showing excellent results.
Announcement of acceptance into the FDA’s Pilot TAP Program to support device development.
Notification of FDA breakthrough device designation for the Phoenix device.
An article discussing the medical need, market opportunity, and Evren's innovative solution for PTSD.
Profiles of key team members and scientific advisors working on PTSD treatments.
Evren is partnered with Emory University and Dr. Doug Bremner, a leading PTSD researcher, supporting soldier safety and performance.
The company announced the completion of an IRB-approved pilot study using the Phoenix device, showing excellent results.
Announcement of acceptance into the FDA’s Pilot TAP Program to support device development.
Notification of FDA breakthrough device designation for the Phoenix device.
An article discussing the medical need, market opportunity, and Evren's innovative solution for PTSD.
Profiles of key team members and scientific advisors working on PTSD treatments.